BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34034418)

  • 1. [Preoperative treatment of uterine fibroids with low-dose mifepristone: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study].
    Bian ML; Huang ML; Zhang ZY; Liu SM; Sun J; Fang F; Gu YP; Liu CD; Yao C
    Zhonghua Fu Chan Ke Za Zhi; 2021 May; 56(5):317-327. PubMed ID: 34034418
    [No Abstract]   [Full Text] [Related]  

  • 2. Different dosages of mifepristone versus enantone to treat uterine fibroids: A multicenter randomized controlled trial.
    Liu C; Lu Q; Qu H; Geng L; Bian M; Huang M; Wang H; Zhang Y; Wen Z; Zheng S; Zhang Z
    Medicine (Baltimore); 2017 Feb; 96(7):e6124. PubMed ID: 28207540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
    Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
    Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mifepristone for uterine fibroids.
    Tristan M; Orozco LJ; Steed A; Ramírez-Morera A; Stone P
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD007687. PubMed ID: 22895965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Mifepristone vs Placebo for Treatment of Adenomyosis With Pain Symptoms: A Randomized Clinical Trial.
    Che X; Wang J; Sun W; He J; Wang Q; Zhu D; Zhu W; Zhang J; Dong J; Xu J; Zheng F; Zhou J; Zhao W; Lin Q; Ye L; Zhao X; Xu Z; Chen Y; Wang J; Wu W; Zhai L; Zhou Y; Zheng J; Zhang X
    JAMA Netw Open; 2023 Jun; 6(6):e2317860. PubMed ID: 37307001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids.
    Al-Hendy A; Venturella R; Arjona Ferreira JC; Li Y; Soulban G; Wagman RB; Lukes AS
    Am J Obstet Gynecol; 2023 Dec; 229(6):662.e1-662.e25. PubMed ID: 37666383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ulipristal acetate versus placebo for fibroid treatment before surgery.
    Donnez J; Tatarchuk TF; Bouchard P; Puscasiu L; Zakharenko NF; Ivanova T; Ugocsai G; Mara M; Jilla MP; Bestel E; Terrill P; Osterloh I; Loumaye E;
    N Engl J Med; 2012 Feb; 366(5):409-20. PubMed ID: 22296075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vilaprisan in women with uterine fibroids: the randomized phase 2b ASTEROID 1 study.
    Bradley LD; Singh SS; Simon J; Gemzell-Danielsson K; Petersdorf K; Groettrup-Wolfers E; Ren X; Zvolanek M; Seitz C
    Fertil Steril; 2019 Feb; 111(2):240-248. PubMed ID: 30527839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of vilaprisan in women with uterine fibroids: data from the ASTEROID 3 randomized controlled trial.
    Al-Hendy A; Zhou YF; Faustmann T; Groettrup-Wolfers E; Laapas K; Parke S; Seitz C
    F S Sci; 2023 Nov; 4(4):317-326. PubMed ID: 37437885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.
    Al-Hendy A; Lukes AS; Poindexter AN; Venturella R; Villarroel C; Critchley HOD; Li Y; McKain L; Arjona Ferreira JC; Langenberg AGM; Wagman RB; Stewart EA
    N Engl J Med; 2021 Feb; 384(7):630-642. PubMed ID: 33596357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized double-blind trial comparing low dose and conventional dose of a modified traditional herbal formula Guizhi Fuling Wan in women with symptomatic uterine fibroids.
    Meng W; Lin WL; Yeung WF; Zhang Y; Ng EHY; Lee YPE; Zhang ZJ; Rong J; Lao L
    J Ethnopharmacol; 2022 Jan; 283():114676. PubMed ID: 34562564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
    Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Chinese herbal prescriptions containing Ejiao or Velvet antler for management of uterine fibroids: a systematic review and meta-analysis of randomized controlled trials.
    Li Q; Zhang L; Qian X; Ma Y; Yang W; Yang M; Ye Y
    Ann Palliat Med; 2021 Aug; 10(8):8772-8786. PubMed ID: 34488366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of uterine leiomyoma by two different doses of mifepristone].
    Yang Y; Zheng S; Li K
    Zhonghua Fu Chan Ke Za Zhi; 1996 Oct; 31(10):624-6. PubMed ID: 9275461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose mifepristone in treatment of uterine leiomyoma: a randomised double-blind placebo-controlled clinical trial.
    Bagaria M; Suneja A; Vaid NB; Guleria K; Mishra K
    Aust N Z J Obstet Gynaecol; 2009 Feb; 49(1):77-83. PubMed ID: 19281585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mifepristone versus placebo to treat uterine myoma: a double-blind, randomized clinical trial.
    Esteve JL; Acosta R; Pérez Y; Rodriguez B; Seigler I; Sanchez C; Tomasi G
    Int J Womens Health; 2013; 5():361-9. PubMed ID: 23843709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herbal preparations for uterine fibroids.
    Liu JP; Yang H; Xia Y; Cardini F
    Cochrane Database Syst Rev; 2013 Apr; (4):CD005292. PubMed ID: 23633329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
    Barlow DH; Lumsden MA; Fauser BC; Terrill P; Bestel E
    Hum Reprod; 2014 Mar; 29(3):480-9. PubMed ID: 24457604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids.
    Al-Hendy A; Bradley L; Owens CD; Wang H; Barnhart KT; Feinberg E; Schlaff WD; Puscheck EE; Wang A; Gillispie V; Hurtado S; Muneyyirci-Delale O; Archer DF; Carr BR; Simon JA; Stewart EA
    Am J Obstet Gynecol; 2021 Jan; 224(1):72.e1-72.e50. PubMed ID: 32702363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.